NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 254 filers reported holding NATERA INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,387,105 | -10.6% | 31,347 | -1.7% | 0.00% | 0.0% |
| Q2 2023 | $1,551,086 | +625.8% | 31,876 | +499.2% | 0.00% | – |
| Q4 2022 | $213,704 | -22.3% | 5,320 | -15.2% | 0.00% | – |
| Q3 2022 | $275,000 | -30.9% | 6,275 | +47.1% | 0.00% | – |
| Q4 2021 | $398,000 | -30.8% | 4,267 | -17.4% | 0.00% | -100.0% |
| Q3 2021 | $575,000 | -8.1% | 5,164 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $626,000 | -71.0% | 5,511 | -74.1% | 0.00% | -50.0% |
| Q1 2021 | $2,159,000 | +1.3% | 21,261 | -0.7% | 0.00% | 0.0% |
| Q4 2020 | $2,131,000 | +42.7% | 21,417 | +3.6% | 0.00% | 0.0% |
| Q3 2020 | $1,493,000 | +246.4% | 20,668 | +139.2% | 0.00% | +100.0% |
| Q2 2020 | $431,000 | +55.6% | 8,640 | +5.1% | 0.00% | – |
| Q4 2019 | $277,000 | -36.5% | 8,218 | -48.0% | 0.00% | -100.0% |
| Q2 2019 | $436,000 | – | 15,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |